Literature DB >> 2464662

Failure of acid-ethanol treatment to prevent interference by binding proteins in radioligand assays for the insulin-like growth factors.

S Mesiano1, I R Young, C A Browne, G D Thorburn.   

Abstract

Acid-ethanol precipitation and gel filtration at acidic pH have been widely used to extract circulating binding proteins for insulin-like growth factor (IGF-I and IGF-II) from plasma or serum samples before radioligand assay for the respective IGFs. Gel filtration on Sephadex G-50 at neutral pH of neutralized acid-ethanol extracts of fetal and adult ovine plasma which had been incubated with 125I-labelled IGF-I or 125I-labelled IGF-II revealed that significant amounts of the IGF-binding protein activity survived the acid-ethanol extraction procedure. Radioimmunoassay for IGF-I in acid-ethanol extracts of plasma samples from fetal, neonatal and adult sheep yielded results which depended upon the method used for separation of the antibody-bound IGF-I tracer from the free IGF-I tracer. Acid gel filtration of ovine fetal and adult plasma was found to remove completely the IGF-binding protein activity. Radioimmunoassay for IGF-I in samples of fetal, neonatal and adult sheep plasma that had undergone acid gel chromatography yielded consistent results for both methods that were used to separate antibody-bound IGF-I tracer from the free tracer. Radioreceptor assays for IGF-II were similarly highly perturbed by the presence of binding protein in acid-ethanol extracts of ovine fetal and adult plasma. We conclude that acid-ethanol extraction can not be used reliably for the removal of IGF-binding proteins, and that only acid gel filtration is a completely safe and valid method.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2464662     DOI: 10.1677/joe.0.1190453

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  5 in total

1.  Comparison of two immunoassays in the determination of IGF-I levels and its correlation with oral glucose tolerance test (OGTT) and with clinical symptoms in acromegalic patients.

Authors:  Laura Boero; Marcos Manavela; Karina Danilowicz; Analia Alfieri; Maria Carolina Ballarino; Alberto Chervin; Natalia García-Basavilbaso; Mariela Glerean; Mirtha Guitelman; Monica Graciela Loto; Jose Alberto Nahmías; Amelia Susana Rogozinski; Marisa Servidio; Nicolas Marcelo Vitale; Débora Katz; Patricia Fainstein Day; Graciela Stalldecker; Maria Susana Mallea-Gil
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

2.  Differential removal of insulin-like growth factor binding proteins in rat serum by solvent extraction procedures.

Authors:  K Srivenugopal; S P Singh; X H Yuan; S Ehmann; A K Snyder
Journal:  Experientia       Date:  1994-05-15

3.  Public health implications of bovine somatotropin use in dairying: discussion paper.

Authors:  T B Mepham
Journal:  J R Soc Med       Date:  1992-12       Impact factor: 18.000

Review 4.  IGF-I assays: current assay methodologies and their limitations.

Authors:  David R Clemmons
Journal:  Pituitary       Date:  2007       Impact factor: 3.599

5.  Increased activity of insulin-like growth factor-binding protein in human thyroid papillary cancer tissue.

Authors:  T Yashiro; M Arai; K Shizume; T Obara; H Murakami; N Hizuka; N Emoto; M Miyakawa; K Ito; T Tsushima
Journal:  Jpn J Cancer Res       Date:  1994-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.